✦ LIBER ✦

Cowpea inhibition of human and bovine protease activities and the effects of processing

✍ Scribed by Christina A. Nti; Wisdom A. Plahar

Book ID: 116164550
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 639 KB
Volume: 7
Category: Article
ISSN: 0956-7135
DOI: 10.1016/0956-7135(96)00017-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of activity of the protease f

Inhibition of activity of the protease from bovine leukemia virus

✍ Armelle Me´nard; Regis Leonard; Sabine Llido; Serge Geoffre; Philippe Picard; Fr 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 458 KB

Inhibition and activation of venom prote

Inhibition and activation of venom proteases

✍ V.B. Philpot Jr.; H.F. Deutsch 📂 Article 📅 1956 🏛 Elsevier Science ⚖ 439 KB

Identification and characterization of I

Identification and characterization of Iflavirus 3C-like protease processing activities

✍ Shan Ye; Hongjie Xia; Chen Dong; Zhenyun Cheng; Xiaoling Xia; Jiamin Zhang; Xi Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 967 KB

Gel diffusion methods for determination

Gel diffusion methods for determination of protease and protease-inhibiting activities

✍ L. Carlsson; B. Karlsson 📂 Article 📅 1972 🏛 Springer 🌐 English ⚖ 341 KB

Inhibition of human immunodeficiency vir

Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins

✍ T.B. Ng; T.L. Lam; T.K. Au; X.Y. Ye; C.C. Wan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Metals affect the structure and activity

Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition

✍ Lawrence C. Thompson; Sumit Goswami; David S. Ginsberg; Duane E. Day; Ingrid M. 📂 Article 📅 2011 🏛 Cold Spring Harbor Laboratory Press 🌐 English ⚖ 1023 KB

## Abstract Human plasminogen activator inhibitor type 1 (PAI‐1) is a serine protease inhibitor with a metastable active conformation. Under physiological conditions, half of the inhibitor transitions to a latent state within 1–2 h. The interaction between PAI‐1 and the plasma protein vitronectin p